Bioretec

Tampere, Finland Founded: 1985 • Age: 41 yrs
Provider of bioabsorbable, bioactive and drug-releasing surgical implants
Request Access

About Bioretec

Bioretec is a company based in Tampere (Finland) founded in 1985.. Bioretec has raised $8.58 million across 4 funding rounds from investors including Springvest. The company has 47 employees as of December 31, 2024. Bioretec has completed 1 acquisition, including BRI.Tech. Bioretec offers products and services including RemeOs and Activa. Bioretec operates in a competitive market with competitors including Treace Medical Concepts, Loci Orthopaedics, IlluminOss Medical, Stanmore Implants and Medartis, among others.

  • Headquarter Tampere, Finland
  • Employees 47 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioretec Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $4.72 M (USD)
    16.32
    as on Dec 31, 2024
  • Net Profit
    $-4.79 M (USD)
    -21.78
    as on Dec 31, 2024
  • EBITDA
    $-4.21 M (USD)
    -43.07
    as on Dec 31, 2024
  • Total Equity Funding
    $8.58 M (USD)

    in 4 rounds

  • Latest Funding Round
    $6.32 M (USD), Post-IPO

    Nov 27, 2024

  • Investors
  • Employee Count
    47

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bioretec

Bioretec is a publicly listed company on the OMXHEX with ticker symbol BRETEC in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OMXHEX · Ticker: BRETEC . Sector: Health technology · Finland

Products & Services of Bioretec

Bioretec offers a comprehensive portfolio of products and services, including RemeOs and Activa. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Innovative metal alloy for promoting natural bone healing without removal surgery

Biopolymer products that facilitate bone healing and reduce patient discomfort

People of Bioretec
Headcount 10-50
Employee Profiles 6
Board Members and Advisors 4
Employee Profiles
People
Rami Ojala
Sales & Marketing Director
People
Sarah Van Hellenberg Hubar-Fisher
CEO
People
Timo Lehtonen
Chief Technology Officer
People
Frank Sarcone
Vice President Of Sales US

Unlock access to complete

Board Members and Advisors
people
Antti Vasara
Board Member

Unlock access to complete

Funding Insights of Bioretec

Bioretec has successfully raised a total of $8.58M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.32 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $6.3M
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2024 Amount Post-IPO - Bioretec Valuation

investors

Apr, 2023 Amount Post-IPO - Bioretec Valuation

investors

Jun, 2021 Amount Series A - Bioretec Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Bioretec

Bioretec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Springvest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Springvest is recognized as a leading growth investment service in Finland.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Bioretec

Bioretec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BRI.Tech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Orthopedic surgical instruments are manufactured by BRI.Tech in Germany.
0
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Bioretec

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioretec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bioretec

Bioretec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Treace Medical Concepts, Loci Orthopaedics, IlluminOss Medical, Stanmore Implants and Medartis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Orthopedic foot and ankle correction systems are developed and offered.
domain founded_year HQ Location
Thumb implant for thumb base arthritis
domain founded_year HQ Location
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
domain founded_year HQ Location
Modular implants for limb sparing and complex primary and revision joint replacement
domain founded_year HQ Location
Metal implants for orthopedic fracture fixation are developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioretec

Frequently Asked Questions about Bioretec

When was Bioretec founded?

Bioretec was founded in 1985 and raised its 1st funding round 33 years after it was founded.

Where is Bioretec located?

Bioretec is headquartered in Tampere, Finland.

Who is the current CEO of Bioretec?

Tomi Numminen is the current CEO of Bioretec.

Is Bioretec a funded company?

Bioretec is a funded company, having raised a total of $8.58M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.58M, raised on Sep 11, 2018.

How many employees does Bioretec have?

As of Dec 31, 2024, the latest employee count at Bioretec is 47.

What is the annual revenue of Bioretec?

Annual revenue of Bioretec is $4.72M as on Dec 31, 2024.

What does Bioretec do?

Bioretec was founded in 1985 in Tampere, Finland, and operates within the medical device sector. Bioabsorbable, bioactive, and drug-releasing implants are offered, including pins, nails, interference screws, and antibiotic-releasing screws, along with related instruments. These products are utilized for fixing radial head fractures, tibiofibular syndesmosis, bone fractures, osteotomies, and osteochondral fractures, particularly where infection risks from ciprofloxacin-sensitive organisms are present.

Who are the top competitors of Bioretec?

Bioretec's top competitors include Treace Medical Concepts, Loci Orthopaedics and Atreon Orthopedics.

What products or services does Bioretec offer?

Bioretec offers RemeOs and Activa.

Is Bioretec publicly traded?

Yes, Bioretec is publicly traded on OMXHEX under the ticker symbol BRETEC.

How many acquisitions has Bioretec made?

Bioretec has made 1 acquisition, including BRI.Tech.

Who are Bioretec's investors?

Bioretec has 1 investor. Key investors include Springvest.

What is Bioretec's ticker symbol?

The ticker symbol of Bioretec is BRETEC on OMXHEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available